Medical Xpress news
Medical Xpress / The brain's default mode network splits into 'sender' and 'receiver' zones, study finds
The default mode network (DMN) is a distributed set of interconnected brain regions that has long been associated with internally oriented cognition, such as remembering the past, thinking about the future, or thinking about ...
Medical Xpress / New drug combination doubles down on Alzheimer's treatments
A new study has found that combining the current medications for Alzheimer's disease with small molecules derived from micronutrients found in grapes, berries, peanuts and turmeric is a safer and more effective way to treat ...
Medical Xpress / New biological marker of early-stage Alzheimer's disease uncovered
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive memory loss and a decline in mental functions. These symptoms are known to arise from an abnormal buildup of proteins known as amyloid ...
Medical Xpress / Coffee's sweet spot may help mental health in the long run
Your morning cup of coffee may be more than just a pick-me-up. It may also be a simple boost for your mental well-being. In a recent study, researchers from Fudan University, China, wanted to find out whether the amount of ...
Medical Xpress / Shifts in cancer mortality: Place of living increasingly determines where historic drop in cancer mortality reaches
In 1991, the U.S. experienced a significant shift in cancer death rates, as, for the first time, deaths began a steady decline that continues to the present day. Researchers at Mississippi State's Social Science Research ...
Medical Xpress / Experimental drug cuts Parkinson's-linked protein up to 60% in early trial
An experimental drug designed to silence a gene strongly linked to Parkinson's disease has shown encouraging effects in a first-in-human clinical trial, according to a study published in Nature Medicine. The drug, known as ...
Medical Xpress / Researchers map prostate immune niches, showing T cells persist months in mice
More than 35,000 men in the United States die from prostate cancer each year. Now, a new study reveals the immune cell weaponry we might use to save lives.
Medical Xpress / New yellow fever vaccine matches safety and effectiveness of current shot
Yellow fever is a viral disease that is spread to humans through the bites of infected mosquitoes. The symptoms range from mild fever-like aches and pains to severe liver disease with bleeding, often accompanied by yellowing ...
Medical Xpress / Molecular maps reveal how allergic reactions work and a new way to block them
Allergy affects more than one billion people worldwide—and the number is rising. For many, it means mild symptoms such as itching and a runny nose. For others, it can develop into life-threatening reactions. Now, two new ...
Medical Xpress / Genetic variants in 1 in 10 people may reduce blood‑sugar response to GLP‑1 diabetes drugs
More than a quarter of people with Type 2 diabetes take GLP-1 receptor agonists, but the popular diabetes drugs might not work as well for people who have certain genetic variants, according to a new study by Stanford Medicine ...
Medical Xpress / Hippocampal pathways once thought separate converge to integrate 'where' and 'why' in reward processing
New research from the University of Maryland, Baltimore County (UMBC) reveals how two different parts of the brain's memory center team up in a key reward region to help mice—and likely humans—combine memories of places and ...
Medical Xpress / Reprogramming regulatory T cells could help immunotherapy work in pancreatic cancer
Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in pancreatic cancer—and identified a promising strategy to overcome that resistance. The study, published ...
